SCHEMBL5376712

SCHEMBL5376712

Cc1ccc(S(=O)(=O)Nc2ccc(-c3nnc(C4CCCCC4)o3)cc2)cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
POLB P06746 2/20 0.52
MAPT P10636 4/20 0.48
TP53 P04637 3/20 0.48
ALDH1A1 P00352 3/20 0.45
ALOX15B O15296 1/20 0.45
KMT2A Q03164 2/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 4/20 0.43
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PKM P14618 1/20 0.42
ADCY8 P40145 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373785 0.92 CA1 (0.51) CA1CA2POLBMAPTTP53
SCHEMBL5376808 0.81 POLB (0.56) POLBMAPTTP53ALDH1A1KMT2A
SCHEMBL5376622 0.79 PABPC1 (0.57) POLBMAPTTP53ALDH1A1KMT2A
SCHEMBL28760394 0.78 POLB (0.50) POLBMAPTTP53ALDH1A1KMT2A
SCHEMBL5378686 0.76 POLB (0.61) POLBMAPTTP53ALDH1A1LMNA
SCHEMBL5921914 0.75 POLB (0.49) POLBMAPTTP53ALDH1A1KMT2A
SCHEMBL15793152 0.75 MAPT (0.59) CA1CA2MAPTTP53ALDH1A1
SCHEMBL5501882 0.74 POLB (0.70) CA1CA2POLBMAPTALDH1A1
SCHEMBL5380640 0.73 MEN1 (0.57) POLBMAPTTP53ALDH1A1KMT2A
SCHEMBL5377059 0.73 PTPN5 (0.70) MAPTKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD CA1 4881/4885CA2 4864/4885POLB 1807/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD CA1 4879/4885CA2 4852/4885POLB 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.